Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 15, 1998Journal of Clinical InvestigationOpen Access

Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum.

View Full Paper
Ask AI
Bookmark
Share

Authors

MKMarko KornmannUniversity Hospital UlmNANadir ArberTel Aviv Sourasky Medical CenterMKMurray KorcThe Wistar Institute

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kornmann et al. (1998) studied this question.

synapsesocial.com/papers/6a173fdabdf43c780a785bbbhttps://doi.org/10.1172/jci1323
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1In Vivo Association of E2F and DP Family Proteins1995 · 251 citations
  2. 2G <sub>1</sub> Events and Regulation of Cell Proliferation1989 · 2,206 citations
  3. 3Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha.1992 · 494 citations
  4. 4Primary Bioassay of Human Tumor Stem Cells1977 · 1,653 citations
  5. 5Production of transforming growth factor alpha in human pancreatic cancer cells: evidence for a superagonist autocrine cycle.1987 · 223 citations